Innate Pharma SA (Euronext Paris: IPH; Nasdaq: IPHA) (“Innate” or the “Company”), today announced that the Company will hold a conference call on Thursday, March 24, 2022 at 2 p.m. CET / 9 a.m. ET, following the release of its financial results for the full year ending December 31, 2021.
Speakers during the call will be:
- Mondher Mahjoubi, Chief Executive Officer
- Joyson Karakunnel, Executive Vice President, Chief Medical Officer
- Yannis Morel, Executive Vice President, Product Portfolio Strategy & Business Development
- Frédéric Lombard, Senior Vice President, Chief Financial Officer
Details for the Virtual Event
The live webcast will be available at the following link:
https://event.on24.com/wcc/r/3577447/6B0C866D3C3BB7A70F1BAAD02F7320D2.
Participants may also join via telephone using the dial-in details below:
France: 0805 620 704
United States: 1 844 200 6205 / 1 646 904 5544
United Kingdom: 44 208 0682 558 / 44 808 189 648
All other locations: +1 929 526 1599
Access code: 834852
This information can also be found on the Investors section of the Innate Pharma website, www.innate-pharma.com. A replay of the webcast will be available on the Company website for 90 days following the event.
| Press Release in English | 146.15 KB |
| Communiqué en français | 149.48 KB |